Oscar Health, Inc. ( (OSCR) ) has released its Q2 earnings. Here is a breakdown of the information Oscar Health, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oscar Health, Inc. is a healthcare technology company that focuses on providing Individual & Family plans and health technology solutions, aiming to make healthcare more accessible and affordable. In its latest earnings report for the second quarter of 2025, Oscar Health announced a significant increase in total revenue, reaching approximately $2.9 billion, up from $2.2 billion in the same period last year. However, the company also reported a net loss of $228.4 million, a stark contrast to the net income of $56.2 million in the second quarter of 2024. This loss was primarily attributed to an increased medical loss ratio of 91.1%, up from 79.0% the previous year, driven by higher market morbidity.
The company’s membership grew significantly, with total members reaching over 2 million, compared to 1.58 million in the previous year. Despite the revenue growth, the increased medical expenses and risk adjustment transfer accruals impacted the overall financial performance. The SG&A expense ratio improved slightly to 18.7% from 19.6%, indicating better cost management despite the challenging market conditions.
Oscar Health’s CEO, Mark Bertolini, expressed confidence in the long-term potential of the individual market, stating that the company is well-positioned to navigate the current market reset. The company remains optimistic about stabilizing the market by next year and anticipates a return to profitability in 2026. Oscar Health continues to focus on building a healthcare marketplace that caters to both consumers and businesses, aiming for sustained growth in the future.